Fibrolamellar hepatocellular carcinoma
Information
- Disease name
- Fibrolamellar hepatocellular carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05681949 | Not yet recruiting | N/A | Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards | November 2023 | July 2025 |
| NCT05937295 | Recruiting | Phase 1 | FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined With Immune Checkpoint Inhibition | September 26, 2023 | January 2027 |
| NCT06027086 | Recruiting | Phase 1/Phase 2 | DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) | February 6, 2024 | February 1, 2027 |
| NCT01215565 | Terminated | Phase 2 | Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma | October 2009 | May 2012 |
| NCT02702960 | Withdrawn | Phase 2 | Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) | March 2016 | January 3, 2018 |